Laura B Kenzhina

Dr. Laura B Kenzhina

Institute of radiation safety and ecology of National Nuclear Center of Kazakhstan, Kurchatov, Kazakhstan
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
LKLaura B Kenzhina
Laura B Kenzhina
AMAigul N. Mamyrbayeva
Aigul N. Mamyrbayeva
SLSergey Nikolaevich Lukashenko
Sergey Nikolaevich Lukashenko
ZBZhanat A Baigazinov
Zhanat A Baigazinov
DBDina Biyakhmetova
Dina Biyakhmetova
ATAntonella Testa
Antonella Testa
Kazakhstan is known as a country with a complex radioecological situation resulting from different sources such as a natural radiation background, extensive activities of the industrial system of the former Soviet Union and a well-known testing of nuclear power weapons occurred in the Semipalatinsk Test Site (STS) area. The present study focuses on the assessment of the background of dicentric chromosomes in Kazakhstan’s population, which is the starting point in the dose assessment of irradiated people, since the baseline level of spontaneous dicentrics can vary significantly in different populations. In this context, aiming to determine the background frequency of chromosome aberrations in the population of Kazakhstan, considering the heterogeneity of natural radiation background levels of its large territory, a selection of 40 control subjects living in four cities of North, South, West and East Kazakhstan was performed. The cytogenetic study on the selected groups showed fairly low background frequency values of chromosome aberrations (0.84 ± 0.83 per 1000 cells), comparable with other data in the literature on general populations, reporting background frequency values between 0.54 and 2.99 per 1000 cells. The obtained results should be taken into account when constructing the dose–effect calibration curve used in cytogenetic biodosimetry, as a “zero” dose point, which will reduce the uncertainty in quantifying the individual absorbed dose in emergency radiological situations.

3 April 2026 in Journal of Ecology and Sustainability
Verified
Journal Article
Open access
PDF file
ZBZhanat A Baigazinov
Zhanat A Baigazinov
YPYelena Nikolayevna Polivkina
Yelena Nikolayevna Polivkina
NMNurlan Mukhamediyarov
Nurlan Mukhamediyarov
KZKassym Zhumadilov
Kassym Zhumadilov
SSSayan Salmenbayev
Sayan Salmenbayev
ЕПЕлена Поливкина
Елена Поливкина
One of the current issues of atmospheric pollution is particulate matter (PM). PM can be of both natural and anthropogenic origin. This review summarizes the current concepts of PM, as well as approaches to their classification and toxicological properties. The most significant and dangerous for the environment are particles with aerodynamic sizes of 2.5 and 10 micrometers (PM2.5 and PM10). The main sources of PM include construction, mining, fuel and energy enterprises, as well as road transport. The article provides a comparative analysis of the current environmental standards for PM2.5-10 in Kazakhstan, the Russian Federation, the EU, China, and the USA. In the EU, China, and the USA, there are no single maximum permissible concentration (MPC) limits for PM2.5, as is the case in the Russian Federation and Kazakhstan. However, the EU and USA have stricter average daily and annual MPC limits for PM2.5-10. Analysis of data on the continuous exposure to PM2.5-10 in the EU, China, and the USA has allowed us to identify the main risk groups associated with an increased risk of cardiovascular and respiratory diseases, as well as mortality. The complexity in assessing the toxic effects of PM2.5-10 stems from the significant variability and instability in their chemical composition, morphology, and dispersion properties. The main strategy for managing risks and improving public health outcomes is to reduce levels of PM2.5-10 pollution. In Kazakhstan, government measures to monitor and control the concentration of PM aim to reduce air pollution, but they have not been sufficiently effective in addressing public health risks.

25 April 2026 in NNC RK Bulletin
Verified
Journal Article
Closed access
AMA. D. Mergenbayeva
A. D. Mergenbayeva
STS. Z. Tanatarov
S. Z. Tanatarov
MIM. T. Idinov
M. T. Idinov
LKLaura B Kenzhina
Laura B Kenzhina
BAB. Zh. Atantayeva
B. Zh. Atantayeva
ESE. O. Sabekov
E. O. Sabekov
The study was conducted at the Center of Nuclear Medicine and Oncology (Semey) and is devoted to a comparative dosimetric analysis of external beam radiotherapy planning parameters for locally advanced cervical cancer. Three- dimensional conformal radiotherapy (3D-CRT), intensity-modulated radiation therapy (IMRT), and volumetric modulated arc therapy (VMAT) were compared in terms of dose distribution quality and dose burden to organs at risk. Treatment planning was performed for 25 patients using a TrueBeam linear accelerator with daily patient setup verification based on IGRT/CBCT. Plan quality was evaluated using dose–volume histograms, including D95% for the planning target volume (PTV), conformity index (CI) and homogeneity index (HI), as well as absolute dose parameters (Dmean, Dmax) for organs at risk, in accordance with RTOG criteria and QUANTEC recommendations. The analysis demonstrated that VMAT provided the most favorable dosimetric performance, with a high conformity index (CI = 1,03±0,02) and a low homogeneity index (HI = 0,09±0,02), ensuring more uniform and accurate PTV coverage compared with IMRT and 3D-CRT. A key finding was a substantial reduction in dose burden to pelvic organs at risk: VMAT resulted in an average 25–30% reduction in overall dose compared with 3D-CRT, while the mean dose to the rectum (Dmean) decreased to 33,0 Gy. In addition, VMAT significantly reduced the average treatment delivery time to 5–7 minutes, thereby lowering the risk of intrafraction motion. The obtained results confirm the dosimetric advantages of VMAT and substantiate its feasibility for routine clinical use in a regional oncology center.

9 August 2026 in NNC RK Bulletin
Verified
Journal Article
Open access
PDF file
BKB. A. Kaliyaskarova
B. A. Kaliyaskarova
BAB. A. Abdigamitov
B. A. Abdigamitov
ASA. Sh. Sarsekeev
A. Sh. Sarsekeev
BAB. Zh. Atantayeva
B. Zh. Atantayeva
KSK. B. Serikkanova
K. B. Serikkanova
КСК. Б. Серікканова
К. Б. Серікканова
Radiopharmaceuticals based on ligands targeting the prostate-specific membrane antigen (PSMA) are recognized as the “gold standard” for prostate cancer (PCa) imaging using positron emission tomography (PET). This study presents, for the first time in the Republic of Kazakhstan, the results of adapting an automated one-step radiosynthesis technology and performing a comprehensive quality assessment of the [¹⁸F]PSMA-1007 radiopharmaceutical at the Center for Nuclear Medicine and Oncology (Semey, Abai Region). During the study, the direct nucleophilic radiofluorination protocol was optimized, resulting in a stable radiochemical yield (mean 48%) while reducing the total synthesis time to 35–40 minutes. A full quality control cycle confirmed complete compliance of the final product with the European Pharmacopoeia specifications, including radiochemical purity (97–98%), sterility, and apyrogenicity. The successful implementation of this project represents a strategic milestone in the development of nuclear medicine in Kazakhstan. The validated stability and quality parameters of [¹⁸F]PSMA-1007 provide a scientific and methodological basis for scaling up hightechnology production at future cyclotron facilities across the country. The introduction of this radiopharmaceutical into clinical practice significantly improves the accuracy of prostate cancer staging and recurrence detection in Kazakhstan in accordance with international standards.

25 April 2026 in NNC RK Bulletin
Verified
Journal Article
Closed access
NEN. A. Elemessova
N. A. Elemessova
STS. Z. Tanatarov
S. Z. Tanatarov
MIM. T. Idinov
M. T. Idinov
LKLaura B Kenzhina
Laura B Kenzhina
BAB. Zh. Atantayeva
B. Zh. Atantayeva
NKN. Yu. Karnakova
N. Yu. Karnakova
The study was conducted at the Center of Nuclear Medicine and Oncology of the Abai Region (Semey, Kazakhstan) and was aimed at the quantitative evaluation and optimization of dose planning parameters in patients with head and neck tumors. A retrospective analysis included seven patients (N = 7) treated in 2024, for whom radiotherapy plans were generated using intensity-modulated radiation therapy (Intensity-Modulated Radiation Therapy, IMRT) and volumetric modulated arc therapy (Volumetric Modulated Arc Therapy, VMAT) on a TrueBeam linear accelerator within the Eclipse treatment planning system. The objective of the study was a comparative physical-dosimetric assessment of plan quality with analysis of key dosimetric metrics and logistical efficiency of dose delivery. The analysis demonstrated comparable coverage of the planning target volume (PTV) for both techniques, while clinically significant differences were observed in dose distribution to organs at risk. The use of VMAT resulted in a reduction of the mean dose to the parotid glands by 4,65 Gy compared with IMRT (19,60±7,97 Gy vs. 24,26±3,75 Gy), achieving values below the critical threshold of 25 Gy and contributing to preservation of glandular function. The mean dose to the spinal cord was also lower with VMAT (37,96±4,16 Gy vs. 41,37±1,94 Gy), thereby enhancing radiation safety of treatment. Logistical analysis revealed a clear advantage of VMAT, characterized by more than a 60% reduction in monitor units and dose delivery time compared with IMRT, which contributes to decreased radiation exposure of organs at risk and supports the feasibility of VMAT as a preferred technique in routine clinical practice.

25 April 2026 in NNC RK Bulletin
Verified
Journal Article
Open access
PDF file
AAA. D. Alibekova
A. D. Alibekova
LKLaura B Kenzhina
Laura B Kenzhina
MIM. T. Idinov
M. T. Idinov
BAB. Zh. Atantayeva
B. Zh. Atantayeva
SAS. M. Aitkaliyev
S. M. Aitkaliyev
STS. Z. Tanatarov
S. Z. Tanatarov
This study is dedicated to the dosimetric evaluation of the Deep Inspiration Breath Hold (DIBH) technique as a cardioprotective method during adjuvant radiotherapy for left-sided breast cancer. The primary objective of the research was to compare the dosimetric parameters of radiation exposure to the heart in the DIBH mode with those obtained in the conventional Free Breathing (FB) mode, while maintaining adequate coverage of the Planning Target Volume (PTV). To achieve this objective, a retrospective dosimetric analysis of three-dimensional conformal radiotherapy (3D-CRT) plans for 10 patients was performed. Key dose–volume metrics for the PTV, lungs, heart, esophagus, spinal cord, and contralateral breast were assessed. The results demonstrated that, despite the dosimetric equivalence in PTV coverage and protection of lung parenchyma (V20 Gy), the DIBH technique provides a pronounced protective effect on cardiac structures. In the DIBH mode, a statistically significant reduction of more than 50% in the mean heart dose (Dmean) was observed – from 33,16±3,79 Gy to 15,49±4,50 Gy (p  0,001). The most substantial reduction in radiation exposure was recorded for the left anterior descending coronary artery (LAD). This sparing effect is explained by the physiological caudal displacement of the heart during deep inspiration, effectively increasing the distance between the heart and the irradiation field. Thus, the DIBH technique ensures excellent cardioprotection, significantly reducing long-term cardiovascular risks – particularly those associated with LAD exposure – without compromising the oncological adequacy of treatment. These findings confirm the necessity of implementing DIBH as a gold standard in regional clinical radiotherapy protocols.